Teladoc Health, Inc.

Equities

TDOC

US87918A1051

Healthcare Facilities & Services

Market Closed - Nyse 16:00:02 2024-07-15 EDT 5-day change 1st Jan Change
9.26 USD -1.38% Intraday chart for Teladoc Health, Inc. 0.00% -57.03%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Evercore ISI Lowers Price Target on Teladoc to $10 From $14, Maintains In Line Rating MT
Teladoc Health, Inc. Announces Termination of Laizer Kornwasser as President, Enterprise Growth and Global Markets CI
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell 1000 Index CI
Teladoc Health, Inc.(NYSE:TDOC) added to Russell 2000 Index CI
Teladoc Health, Inc.(NYSE:TDOC) added to Russell 3000 Growth Index CI
Teladoc Health, Inc.(NYSE:TDOC) added to Russell 2000 Value Index CI
Teladoc Health, Inc.(NYSE:TDOC) added to Russell 3000E Growth Index CI
Teladoc Health, Inc.(NYSE:TDOC) added to Russell 2000 Growth Index CI
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell Midcap Index CI
Teladoc Health, Inc.(NYSE:TDOC) added to Russell 2000 Dynamic Index CI
Teladoc Health, Inc.(NYSE:TDOC) added to Russell 2500 Growth Index CI
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell Midcap Value Index CI
Teladoc Health, Inc.(NYSE:TDOC) added to Russell Small Cap Comp Growth Index CI
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell 1000 Value Index CI
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell 1000 Dynamic Index CI
Teladoc Health, Inc. Releases New Data from Two Studies CI
Deutsche Bank Adjusts Teladoc Price Target to $15 From $16, Maintains Hold Rating MT
Teladoc Health, Inc. Announces Chief Executive Office Changes CI
Teladoc Health, Inc. Appoints Charles Divita, III as Director CI
Teladoc Health Appoints Charles Divita as CEO MT
JPMorgan Adjusts Teladoc Price Target to $16 From $19, Maintains Neutral Rating MT
Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating MT
UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating MT
Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating MT
Transcript : Teladoc Health, Inc., Q1 2024 Earnings Call, Apr 25, 2024
Chart Teladoc Health, Inc.
More charts
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
27
Last Close Price
9.26 USD
Average target price
16.21 USD
Spread / Average Target
+75.10%
Consensus
  1. Stock Market
  2. Equities
  3. TDOC Stock
  4. News Teladoc Health, Inc.
  5. Evercore ISI Lowers Price Target on Teladoc to $10 From $14, Maintains In Line Rating